Delivery Order SPE2DB20D1109-SPE2DB25FN54E
Award Date
2/11/25
Potential Completion Date
2/12/25
Potential Value
$5.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $13,170.36 firm fixed-price delivery order has an ultimate completion date of August 16, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,371.23 firm fixed price delivery order was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 25, 2024. The contract has a period of performance through June 26, 2024 and does not have any set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,428.56 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024. The contract has an ultimate completion date of December 9, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML to the Defense Logistics Agency (DLA). The $13,188.88 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 23, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,513.36 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 6, 2024, with a completion date of December 9, 2024. The contract is not designated as a set-aside and represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML autoinjectors to the Defense Logistics Agency (DLA). The $5,311.95 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024 with a completion date of October 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award is for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML to the Defense Logistics Agency (DLA). The $2,825.86 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 30, 2022 and was not designated under any set-aside program. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Aimovig 140 mg/ml autoinjector medication to the Defense Logistics Agency (DLA). The $2,749.26 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of May 6, 2024 and is not designated with a set-aside requirement. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $17,732.40 Firm Fixed Price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on September 21, 2023. The contract has an ultimate completion date of September 22, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The $7,828.00 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on June 5, 2024 with a completion date of June 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds two significant Indefinite Delivery Contracts (IDCs) with federal agencies. The...